Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Browse the complete record of transactions filed by Cardoza George, Director Financiero. Officer active across 2 companies, notably SOPHiA GENETICS SA. Aggregated, 13 reports have been published. Breakdown: 1 buy · 7 sells. Total volume traded: €5.7m. Activity tracked since 2 June 2021. The latest transaction was filed on 6 July 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Cardoza George
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
169.230 títulos@ 40,39 US$100.0% de su flujoCommon StockSEC:0001077183-21-000155:0
13 de 13 declaraciones
About Cardoza George
George Cardoza is the Chief Financial Officer and President of Pharma Services at SOPHiA GENETICS SA and NEOGENOMICS INC. In this role, he oversees the financial and strategic operations of both companies. Cardoza plays a key role in guiding financial strategy and managing resources to ensure growth and innovation. His expertise is essential for the success of both organizations.